President, Chief Technology Officer at Vax-Immune™ Diagnostics, LLC
Baylor College of Medicine
Dr. Weisman has been a research and practicing neonatologist for over 35 years. With more than 250 peer-reviewed publications, he is globally recognized for his work with newborns and infectious disease, and has been the lead investigator in multiple international studies.
Dr. Weisman has been working with Group B Strep for almost 40 years, and for the past decade with Ureaplasma, micro-bacteria, which has been difficult to diagnose and treat, until now. His clinical and laboratory discoveries with IVIG led to the success of MedImmune, which sold for $15.6 Bln in 2007.